The antimicrobial peptide hLF1-11 comprises the first 11 N-terminal amino
acids of the endogenous protein; human lactoferrin. The compound exerts both
antibacterial and antifungal activity against a broad range of microorganisms.
Moreover, it appears that hLF1-11 acts by selectively stimulating the innate
immune system. Overall safety has been established in preclinical and clinical
studies.